Medicare Enrolled
Dr. Brian Costell, M.D.
Neurology · Boca Raton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Costell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Costell? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Costell
Dr. Brian Costell is a neurology in Boca Raton, FL, with 19 years in practice. Based on federal Medicare data, Dr. Costell performed 153,554 Medicare services across 1,734 unique beneficiaries.
Between the years covered by Open Payments, Dr. Costell received a total of $473,436 from 103 pharmaceutical and/or device companies across 2557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Costell is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 0% volume in FL$ $473,436 industry payments
Medicare Practice Summary
Medicare Utilization ↗153,554
Medicare services
Top 0% in FL for neurology
1,734
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,082 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, lecanemab-irmb, 1 mg | 101,664 | $1 | $14 |
| Botox injection, per unit | 38,400 | $5 | $24 |
| Injection, eptinezumab-jjmr, 1 mg | 10,700 | $13 | $31 |
| Office visit, established patient (30-39 min) | 638 | $95 | $562 |
| Office visit, established patient, complex (40-54 min) | 361 | $144 | $788 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 178 | $50 | $280 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 171 | $131 | $772 |
| Administration of chemotherapy into vein, 1 hour or less | 171 | $106 | $626 |
| New patient office visit (45-59 min) | 169 | $131 | $730 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 153 | $52 | $310 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 145 | $17 | $93 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 142 | $79 | $433 |
| Injection, methylprednisolone acetate, 40 mg | 81 | $6 | $11 |
| Nerve conduction, 9-10 studies | 63 | $170 | $960 |
| Administration of chemotherapy into vein, each additional hour | 51 | $23 | $132 |
| Injection of additional new drug or substance into vein | 46 | $13 | $72 |
| New patient office visit (30-44 min) | 44 | $82 | $494 |
| Nerve conduction, 7-8 studies | 41 | $142 | $803 |
| Office visit, established patient (20-29 min) | 39 | $64 | $397 |
| Nerve conduction, 13 or more studies | 34 | $232 | $1,311 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 33 | $62 | $348 |
| Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | 31 | $85 | $495 |
| Drug injection, under skin or into muscle | 28 | $11 | $60 |
| Nerve conduction, 5-6 studies | 24 | $109 | $607 |
| Injection, diphenhydramine hcl, up to 50 mg | 23 | $1 | $4 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 23 | $4 | $24 |
| Punch biopsy, each additional skin growth | 22 | $49 | $265 |
| New patient office visit, complex (60-74 min) | 22 | $174 | $976 |
| Injection of trigger points, 1-2 muscles | 21 | $31 | $245 |
| Measurement of brain wave activity (eeg), awake and drowsy | 14 | $215 | $1,115 |
| Punch biopsy, first skin growth | 11 | $104 | $563 |
| Nerve conduction, 11-12 studies | 11 | $201 | $1,116 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
98.7% medium
1.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$473,436
Total received (2018-2024)
Avg $67,634/year across 7 years
Top 1% in FL for neurology
103
Companies
2,557
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$441,635 (93.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,497 (5.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,303 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$65,665
2023$31,272
2022$33,902
2021$107,771
2020$86,810
2019$76,899
2018$71,117
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$96,719
Amgen Inc.
$79,442
Allergan, Inc.
$43,409
Eisai Inc.
$40,191
AbbVie Inc.
$38,027
ABBVIE INC.
$37,043
Allergan Inc.
$33,987
Teva Pharmaceuticals USA, Inc.
$27,105
Biohaven Pharmaceuticals, Inc.
$18,459
Assertio Therapeutics, Inc.
$11,093
Lundbeck LLC
$5,003
Biohaven Pharmaceutical Holding Company Ltd.
$4,921
Sunovion Pharmaceuticals Inc.
$3,783
AbbVie, Inc.
$3,590
Supernus Pharmaceuticals, Inc.
$3,331
Novartis Pharmaceuticals Corporation
$2,647
ARGENX US, INC.
$2,562
UCB, Inc.
$1,777
CATALYST PHARMACEUTICALS, INC.
$1,722
EMD Serono, Inc.
$1,461
GENZYME CORPORATION
$1,265
Alexion Pharmaceuticals, Inc.
$947
Biogen, Inc.
$839
PFIZER INC.
$736
Genentech USA, Inc.
$709
Takeda Pharmaceuticals U.S.A., Inc.
$674
Amneal Pharmaceuticals LLC
$671
Abbott Laboratories
$523
Egalet US Inc
$503
US WorldMeds, LLC
$496
CSL Behring
$488
Merz Pharmaceuticals, LLC
$424
Neurelis, Inc.
$380
ACADIA Pharmaceuticals Inc
$377
Avanir Pharmaceuticals, Inc.
$370
Mallinckrodt Hospital Products Inc.
$354
Janssen Pharmaceuticals, Inc
$350
Acorda Therapeutics, Inc
$350
Neurocrine Biosciences, Inc.
$333
Octapharma USA, Inc.
$331
ANI Pharmaceuticals, Inc.
$320
Celgene Corporation
$318
Grifols USA, LLC
$286
SCILEX PHARMACEUTICALS INC.
$285
Piramal Imaging Limited
$284
SK Life Science, Inc.
$262
Alnylam Pharmaceuticals Inc.
$247
Harmony Biosciences LLC
$244
MDD US Operations, LLC
$240
IMPEL PHARMACEUTICALS INC.
$232
MITSUBISHI TANABE PHARMA AMERICA, INC.
$225
Ipsen Biopharmaceuticals, Inc
$223
Upsher-Smith Laboratories LLC
$189
JAZZ PHARMACEUTICALS INC.
$153
EISAI INC.
$141
LivaNova USA, Inc.
$124
UPSHER-SMITH LABORATORIES LLC
$122
Merz North America, Inc.
$121
Alfasigma USA, Inc.
$108
Merck Sharp & Dohme Corporation
$102
E.R. Squibb & Sons, L.L.C.
$101
Kyowa Kirin, Inc.
$100
Indivior Inc.
$98
Bausch Health US, LLC
$85
Akcea Therapeutics, Inc.
$77
Medtronic, Inc.
$75
Aprecia Pharmaceuticals, LLC
$70
Adamas Pharmaceuticals, Inc.
$59
Sumitomo Pharma America, Inc.
$59
Horizon Therapeutics plc
$58
Otsuka America Pharmaceutical, Inc.
$58
Impax Laboratories, Inc.
$54
AQUESTIVE THERAPEUTICS, INC.
$54
Mallinckrodt Enterprises LLC
$52
KVK-Tech, Inc.
$46
Corium, LLC
$45
ARBOR PHARMACEUTICALS, INC.
$44
Silk Road Medical, Inc.
$44
Saol Therapeutics Inc.
$43
AstraZeneca Pharmaceuticals LP
$38
Scilex Pharmaceuticals Inc.
$37
Promius Pharma LLC
$36
Boston Scientific Corporation
$36
HARMONY BIOSCIENCES LLC
$34
Vertical Pharmaceuticals, LLC
$34
BOSTON SCIENTIFIC CORPORATION
$34
InSightec,Inc
$33
Avion Pharmaceuticals
$31
Arbor Pharmaceuticals, Inc.
$29
Currax Pharmaceuticals LLC
$27
Mylan Specialty L.P.
$24
Xeris Pharmaceuticals, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$20
Dynasplint Systems Inc.
$20
Ultragenyx Pharmaceutical Inc.
$20
SpringWorks Therapeutics, Inc.
$18
Merck Sharp & Dohme LLC
$18
NOVARTIS PHARMACEUTICALS CORPORATION
$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
Shire North American Group Inc
$14
Greenwich Biosciences, Inc.
$13
Vanda Pharmaceuticals Inc.
$13
ASSERTIO THERAPEUTICS, Inc.
$13
Top 3 companies account for 46.4% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Apokyn · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CAMBIA · CAPLYTA · COMIRNATY · CONTRAVE · COPAXONE · Cambia · Confirm Rx · DUOPA · DYSPORT · Dhivy · Duopa · Dynasplint · Dysport · EMGALITY · ENROUTE Transcarotid Neuroprotection System · EPIDIOLEX · ETERNA · Edarbi · Enspryng · Epidiolex · Evrysdi · Exablate · FIRDAPSE · Fabhalta · Fintepla · Fycompa · GAMMAGARD · GENERAL PAIN MANAGEMENT · GILENYA · GLATIRAMER ACETATE · GOCOVRI · Gamunex-C · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTERSTIM · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LORZONE · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MEROCEL · MIGRANAL · MYDAYIS · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Octrode SCS Leads · Ongentys · PANZYGA · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REVEAL LINQ · REXULTI · REYVOW · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SYMPAZAN · Soliris · Spritam · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · WATCHMAN FLX · Wakix · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in FL.
Equivalent to $308 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
165
Per 100K population
10.9
County median income
$81,115
Nearest hospital
WEST BOCA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Costell is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Costell experienced with injection, lecanemab-irmb, 1 mg?
Based on Medicare claims data, Dr. Costell performed 101,664 injection, lecanemab-irmb, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Costell receive payments from pharmaceutical companies?
Yes. Dr. Costell received a total of $473,436 from 103 companies across 2,557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Costell's costs compare to other neurologys in Boca Raton?
Dr. Costell's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Costell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Boca Raton
Browse neurologys in Boca Raton ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in FL
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in FL
Which FL neurologys receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology